A multicenter retrospective study of early cardiac toxicity in operable breast cancer patients receiving concurrent dual or mono anti-HER2 therapy with postoperative radiation therapy
Purpose: This study aims to assess whether dual anti-HER2 therapy with trastuzumab and pertuzumab increases early cardiac toxicity compared to trastuzumab alone in breast cancer (BC) patients receiving postoperative radiation therapy (RT). Methods: Consecutive operable BC patients receiving postoper...
Saved in:
| Main Authors: | Jing Yang, Meng-Yun Zhou, Bo Yu, Qing Lin, Yuan Yao, Hua-Ling Wu, Qi-Wei Zhu, Ming Ye, Hua-Ying Xie, Jian-Wei Wu, Gang Cai, Rong Cai, Wei-Xiang Qi, Jia-Yi Chen, Lu Cao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Breast |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977625000086 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The association of BMI and subclinical myocardial dysfunction in breast cancer patients after single or dual anti-HER2 targeted therapy
by: Feng Zhang, et al.
Published: (2024-12-01) -
HER2-positive gastric cancer: from targeted therapy to CAR-T cell therapy
by: Qiangzu Shao, et al.
Published: (2025-03-01) -
Cardiotoxicity of breast cancer drug treatments
by: Maria Haque, et al.
Published: (2025-05-01) -
Cardiac function surveillance practices and outcomes in patients with HER2-positive breast cancer treated with trastuzumab: a retrospective cohort study across a safety-net and tertiary care setting
by: Le Huang, et al.
Published: (2025-08-01) -
Сonsensus statement of Russian experts on the prevention, diagnosis and treatment of cardiotoxicity of anticancer therapy
by: Yu. A. Vasyuk, et al.
Published: (2021-10-01)